Epigenetics and the IRFs: A complex interplay in the control of immunity and autoimmunity

被引:15
|
作者
Rogatsky, Inez [1 ,2 ]
Chandrasekaran, Uma [2 ]
Manni, Michela [2 ]
Yi, Woelsung [2 ]
Pernis, Alessandra B. [2 ,3 ,4 ]
机构
[1] Hosp Special Surg, Arthrit & Tissue Degenerat Program, New York, NY 10021 USA
[2] Weill Cornell Grad Sch Med Sci, Grad Program Immunol & Microbial Pathogenesis, New York, NY USA
[3] Hosp Special Surg, Autoimmun & Inflammat Program, New York, NY 10021 USA
[4] Cornell Univ, Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA
关键词
Autoimmunity; epigenetics; IRF; SLE; transcription factors; REGULATORY FACTOR-I; SYSTEMIC-LUPUS-ERYTHEMATOSUS; TRANSCRIPTION FACTOR IRF4; SEQUENCE BINDING-PROTEIN; HELPER-CELL-DIFFERENTIATION; IFN-GAMMA; GENE-EXPRESSION; SIGNAL TRANSDUCER; VIRUS-INFECTION; INTERFERON INDUCTION;
D O I
10.3109/08916934.2013.853050
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Effective immune responses require the coordinated activation and differentiation of several cell types, including T-cells, B-cells and myeloid cells. Abnormalities in the appropriate regulation of these processes underlie the pathogenesis of many autoimmune disorders, including systemic lupus erythematosus (SLE). Recent studies have revealed that, in addition to sequence-specific DNA-binding factors, the chromatin landscape of a cell can play a pivotal role in controlling these processes and in regulating the onset of autoimmunity. Interferon regulatory factors (IRFs) are emerging as critical regulators of the activation and differentiation of immune cells and deregulation in the expression and/or function of members of the IRF family has increasingly been linked to the pathogenesis of lupus. In this review, we will provide a brief overview of the role of different IRFs in immune responses and SLE development and discuss studies, which highlight the intricate relationship of this family of transcription factors with the epigenetic machinery.
引用
收藏
页码:242 / 255
页数:14
相关论文
共 50 条
  • [41] MicroRNA in immunity and autoimmunity
    Zhu, Shu
    Pan, Wen
    Qian, Youcun
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 2013, 91 (09): : 1039 - 1050
  • [42] The multifaceted interplay between lipids and epigenetics
    Dekkers, Koen F.
    Slagboom, P. Eline
    Jukema, J. Wouter
    Heijmans, Bastiaan T.
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2016, 27 (03) : 288 - 294
  • [43] Interplay between Epigenetics & Cancer Metabolism
    Gupta, Vibhor
    Gopinath, P.
    Iqbal, Mohd Askandar
    Mazurek, Sybille
    Wellen, Kathryn E.
    Bamezai, Rameshwar N. K.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (11) : 1706 - 1714
  • [44] Primer: Immunity and Autoimmunity
    Pietropaolo, Massimo
    Surhigh, Julie M.
    Nelson, Patrick W.
    Eisenbarth, George S.
    [J]. DIABETES, 2008, 57 (11) : 2872 - 2882
  • [45] Transmethylation in immunity and autoimmunity
    Lawson, Brian R.
    Eleftheriadis, Theodoros
    Tardif, Virginie
    Gonzalez-Quintial, Rosana
    Baccala, Roberto
    Kono, Dwight H.
    Theofilopoulos, Argyrios N.
    [J]. CLINICAL IMMUNOLOGY, 2012, 143 (01) : 8 - 21
  • [46] COVID immunity and autoimmunity
    Jose, Bijoy
    Umesh, Saraf
    Kannoth, Sudheeran
    Gopinath, Siby
    Anandakuttan, Anandkumar
    Mathai, Annamma
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [47] ANTIIDIOTYPIC IMMUNITY IN AUTOIMMUNITY
    BIGAZZI, PE
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1986, 475 : 66 - 80
  • [48] Antiinfection immunity and autoimmunity
    Zinkernagel, RM
    [J]. IMMUNOLOGY OF DIABETES: AUTOIMMUNE MECHANISMS AND THE PREVENTION AND CURE OF TYPE 1 DIABETES, 2002, 958 : 3 - 6
  • [49] Epigenetics changes associated to environmental triggers in autoimmunity
    Canas, Carlos A.
    Canas, Felipe
    Bonilla-Abadia, Fabio
    Ospina, Fabio E.
    Tobon, Gabriel J.
    [J]. AUTOIMMUNITY, 2016, 49 (01) : 1 - 11
  • [50] INTERSECTION OF EPIGENETICS AND IMMUNITY IN DIPG
    Martin, Allison
    Bell, Robert
    Eberhart, Charles
    Raabe, Eric
    Koldobskiy, Michael
    [J]. NEURO-ONCOLOGY, 2018, 20 : 64 - 64